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Chapter 1: Introduction
All organisms employ large ribonucleoprotein complexes known as ribosomes 
in order to catalyze the process of protein synthesis. From our earliest understanding 
as an RNA scaffolding unit solely extant for the positioning of the proteins 
responsible for performing the process of translation, to the more recent 
understanding of the ribosome as a ribozyme [1,2], the ribosome's central role in the 
function of the cell has made it a subject of intense scrutiny. Recent research, 
however, has focused on the centrality of the rRNA to the functions of the ribosome, 
instead of the ribosomal proteins [3].
Maintenance of Frame by the Translating Ribosome
Since the role of the ribosome is primarily to translate mRNA into 
polypeptides, maintenance of translational reading frame is a crucial aspect of its 
function. Despite this stricture, a surprising number of elements work to undermine 
this function. Slipping, hopping, and shunting all allow the ribosome to deviate from 
normal decoding rules [4,5]. Programmed ribosomal frameshifting (PRF) is the most 
widespread variant of such mechanisms; it is found in animal, plant, and fungal 
viruses, bacteriophages, and even some cellular genes [6-8]. PRF is a non-random 
response to cis- acting signals within mRNA transcripts that cause translating 
ribosomes to shift reading frame, usually by a single nucleotide in the 5’ (-1) or 3’ 
(+1) direction, allowing them to continue elongation in the new frame (Figure 1; 
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[4,6,7,9-11]). These cis-acting signals and their corresponding effects on PRF are 
well characterized; trans-acting factors less well so. Many viruses of clinical, 
veterinary, and agricultural importance use PRF as a method of maximizing coding 
space in a space-limiting genome [12-14]. Additionally, PRF can serve as a 
regulatory mechanism to control the relative amounts of proteins produced. For 
example, the L-A virus of yeast employs a -1 PRF to produce its Gag-pol fusion 
protein [15,16], and if this delicate balance is disturbed by a change in PRF 
efficiency, virus maintenance is placed in jeopardy [reviewed in 17]. Such a change 
in −1 PRF efficiency in this case results also in the loss of the killer phenotype due to 
the loss of L-A 's M1 satellite virus, which encodes a killer toxin [reviewed in 18]. 
Similarly, Ty1, a yeast retrotransposable element, uses +1 PRF to produce its Gag-pol 
protein, a process which evidences a similar sensitivity to changes in frameshifting 
efficiencies as its -1 PRF counterpart. Remarkably, the basic molecular mechanisms 
of -1 PRF is identical in yeast and humans [6,17].
Ribosomal Proteins and Maintenance of Frame
This serendipitous relationship between ribosome function and viral 
maintenance can be manipulated to examine ribosomal component function 
[reviewed in 7]. PRF efficiency can be affected by various structural modifications 
within the  ribosome that lead to alterations of normal ribosome function. Previous 
findings have linked changes in +1 PRF to changes in the translocation step of the 
translation elongation pathway [19] and -1 PRF to the accomodation step (Figure 1; 
[11]).  The natures of two large subunit proteins, for example, have previously
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Figure 1: The ‘integrated model’ of programmed  ribosomal frameshifting
In Ty 1-mediated +1 PRF (a), the presence of the AGG in the 0-frame of the heptameric CUU AGG C 
‘slippery site’ (where the incoming frame is indicated by spaces) causes elongating ribosomes to pause 
while awaiting delivery of the rare CCU-tRNAArg. Slippage of the ribosome by one base in the 3′ 
direction during this pause allows the P-site tRNA to base-pair to the +1-frame GGC codon. The new 
A-site codon corresponds to the highly abundant CCG-tRNAGly. When viewed in the context of the 
elongation cycle, this slip can only occur when the A-site is empty; that is, after translocation and 
before insertion of aa-tRNA in complex with eukaryotic Elongation Factor 1A (eEF1A) into the A-site. 
The elongation cycle (b) can be divided into four general steps: (1) selection of cognate aminoacyl-
tRNA (aa-tRNA); (2) accommodation of the 3′ end of the aa-tRNA into the ribosomal A-site; (3) 
peptidyl transfer; and (4) eukaryotic Elongation Factor 2 (eEF2) mediated translocation. In a −1 PRF 
signal (c) an mRNA pseudoknot causes elongating ribosomes to pause with their A- and P-site tRNAs 
positioned over the heptameric X XXY YYZ ‘slippery site’ (where the incoming frame is indicated by 
spaces). The G GGU UUA slippery site from the L-A dsRNA virus of yeast is shown here. While 
paused at the slippery site, if the ribosome shifts by one base in the 5′ direction, the non-wobble bases 
of both the A- and P-site tRNAs can re-pair with the new −1-frame codons. As both A- and P-sites 
must be occupied by tRNAs, in theory this shift should occur after step 1 but before step 4 of the 
elongation cycle (indicated by black and red dotted lines). The experimental data suggest that the −1 
shift is actually limited to pre-peptidyltransfer ribosomes (black dotted lines). Taken from [11]; used 
with permission.
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been elucidated by our lab in this fashion. Cells with the mak8-1 allele of RPL3 were 
found to be unable to maintain the killer phenotype [20,21], and were later found to 
have elevated -1 PRF efficiencies [22]. Ribosomes isolated from cells with mak8 
alleles showed decreased peptidyltransferase activities [23], reinforcing the idea that 
post-accomodation ribosomes with both A and P sites occupied pause for longer 
periods of time at -1 frameshift signals, thus increasing -1 PRF efficiency [24]. The 
residues involved in the mutants studied are highly conserved, and located near the 
peptidyltransferase center [25]. Mutants of RPL5, on the other hand, caused increased 
frameshifting efficiencies in both the -1 and the +1 directions. Further analyses of 
these mutants using pharmacological methods found that sparsomcycin, a known P-
site associated peptidyltransferase inhibitor [26],was antagonistic to the frameshifting 
defeects, which points to L5's role in anchoring peptidyl tRNA to the P site [27].
RPL10
In yeast, L10, a 25.4 kDa ribosomal large subunit protein, is encoded by the 
single-copy essential gene RPL10. It has also been previously identified as GRC5 
(GRowth Control; [28]), QSR1 (Quinol-cytochrome c reductase Subunit Requiring; 
[29]), and RIX7 (RIbosomal eXport; [30]) . Its expression has been linked to the 
suppression of tumors in a Wilm's tumor cell line [31], and is it is known to be 
essential for subunit joining [32] and for 60s subunit stability [33]. It has no exact 
counterpart in E.coli, but in archaea, plants, and animals there are homologues 
(Figure 2; [31,34,35]). L10 is located on the lateral stalk of the large subunit, and 
makes contact with almost all of the functional regions of the large subunit: 5S rRNA, 
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the A-minor motif in helix 38, helix 39, the GTPase-associated center, and the P-loop 
(Figure 3; [25]). Given its location, one would expect mutations of this strategically 
placed protein to yield information about how general structure of ribosomal proteins 
may influence function, and, specifically, whether L10 is functionally 
compartmentalized or whether it is responsible for coordinating information from the 
many regions of the ribosome it contacts, as well as indicate with more precision the 
roles of L10 within the ribosome.
RPL10 mutants
With this goal in mind, our lab obtained a variety of RPL10 alleles from the 
lab of Dr. Arlen Johnson (Table 1). These alleles had been found, in unrelated 
screens, to express various mutant phenotypes. ts942 was found by the Jacobsen lab 
via a temperature-sensitivity screen for factors involved in mRNA turnover – a 
process in which translation plays an important part. This point mutation was found 
to decrease the decay rates of unstable mRNAs, even though overall protein synthesis 
was not decreased [35].
Microscopic study and FACs analysis of grc5-1ts  indicated a role for L10 in 
cell morphology and in growth regulation [37], and this mutant displayed a half
-mer phenotype in polysome profiles, due to the disruption of intersubunit binding 
[38,32]. Intriguingly, a nearby double-amino acid substitution, qsr1-24, displayed a
considerably different phenotype than its neighbor; it was found to have only a slight
temperature dependent loss of viability and did not show the previous phenotype's 
related accumulation of cell wall material [39]. A fourth mutation, qsr1-1, has been
5
Figure 2: RPL10 Homology
ClustalW alignment [36] of human, yeast, and H. marismortui RPL10 sequences. 
Boxes enclose mutation sites addressed in this study.
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Figure 3: L10 and environment
L10 is located between many major players in the translating ribosomes. Pictured 
here is L10e (“H-chain”) and nearby large subunit rRNA, color-coded according to 
region.
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Table 1: Yeast Strains
8
strain mutation genotype references
ts942 F85S Zuk et al 99
G161A Koller et al 96
qsr1-24 KI164-5WM Eisinger et al 97
qsr1-1 G194A Tron et al 95
JD1243 wild type Zuk et al 99
JD758 - Tumer et al 98
JD759 - Tumer et al 98
MATa lys2∆0 met15∆0 leu2∆0 ura3∆0 his3∆0
grc5-1ts MATa leu2∆0 ura3∆0 grc5-1ts
MATα ade2∆1, ura3∆1, trp1∆1, can1∆100 qsr1∆
1::His3 + pDEQ2[CEN LEU2 qsr1-24]
MATα ade2∆1, his3∆11,15, ura3∆1, leu2∆3,112, 
trp1∆1, can1∆100, qsr1∆1
MATa met15∆0 leu2∆0 ura3∆0 his3∆0; 
rpl10::Kan covered by RPL10 URA3 2µ vector
MATa kar1∆1 arg1 L-A HN M1
MATα kar1∆1 arg1 thr(i,x) L-A HN M1
shown to display extremely slow growth due to markedly diminished rates of protein 
synthesis [33], and its polysome profile was remarkably similar to that of qsr1-24. 
Given the phenotypes of these mutations, it seems likely that further information 
regarding L10 could be gleaned from them by applying the methods and tools so 
successfully used on other ribosomal proteins in our lab.
Summary
L10 is a multifunctional protein whose wide range of function is heavily 
influenced by its structure. It seems likely, therefore, that further investigation into 
this intriguing structure/function relationship is likely to yield rich information about 
L10, the ribosome, and the process of translation. I pursued the following: a strictly 
genetic method, focusing on the relationship of ribosome structure to maintenance of 
frame and frameshifting during translation, and a pharmacogenetic analysis to 
investigate the effects of certain antibiotics on mutant forms of RPL10.
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Chapter 2: Materials and Methods
Strains, General Procedures, and Media
The S. cerevisiae strains used in this study were a generous gift from Dr. 
Arlen Jacobsen and are listed in Table 1. Due to their temperature sensitivities, 
mutant strains were grown at 25oC unless otherwise noted. Mating types were 
confirmed as previously described [40]. Confirmation of auxotrophic markers was 
done via replica plating on media lacking the appropriate nutrient. Plates of YPAD, 
YPG, SD, synthetic complete media, and 4.7MB were prepared as described 
previously [41]. DNA sequence analysis was performed by the Center for Biosystems 
Research DNA Sequencing Facility. Escherichia coli strain DH5alpha was used to 
amplify plasmids as needed, and both transformations using this strain and yeast 
transformations were carried out as described previously [42]. Plasmids were purified 
from E. coli using a Qiagen kit, and from yeast by phenol extraction of cellular 
lysates.  Plasmids used in this study are listed in Table 2.
Killer Assay
Cytoduction of the L-A and M1 viruses into rho0 strains was done as 
previously described [41] and cells were picked that were  SD- and YPG+. These 
cells were then scored for their ability to maintain the killer phenotype.
The killer virus assay was carried out as previously described [16]. Yeast 
colonies were replica plated onto 4.7MB plates freshly seeded with  0.5 O.D.595 of the
10
Table 2: Plasmids
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plasmid function source
pJD419 J.D. Dinman
pJD420 J.D. Dinman
pJD421 J.D. Dinman
pJD633 J.D. Dinman
pJD634 J.D. Dinman
pJD635 J.D. Dinman
LEU2 based zero frame reporter
LEU2 based -1 frame reporter
LEU2 based +1 frame reporter
TRP1 based zero frame reporter
TRP1 based -1 frame reporter
TRP1 based +1 frame reporter
killer indicator strain 5 x 47. Killer activity was defined as a zone of growth inhibition 
surrounding K+ colonies after 3 days at 20oC.
dsRNA visualization 
dsRNA of L-A and M1 viruses was visualized using native agarose-TAE gel 
electrophoresis and ethidium bromide staining after total nucleic acid extraction 
performed as described previously [43].
Dual Luciferase Assay
Dual luciferase assays were performed as previously described [44] using 
lysates of cells harboring the appropriate 0-frame, -1 frame, or +1 frame plasmids 
(Table 2). Reactions were carried out using the Dual-Luciferase Reporter Assay 
System from Promega Corporation; readings were obtained using a Turner Designs 
TD20/20 luminometer. The firefly/Renilla activity ratio generated from the zero-
frame reporter was divided into that from the frameshift reporters and multiplied by 
100% to obtain frameshift efficiencies for each recoding signal. All assays were 
performed in triplicate at least three times. Other statistics were performed as 
described in [45].  
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Dilution Spot Assay
Drug sensitivity assays were carried out as described previously [46]. Ten-
fold serial dilutions of equal numbers of cells grown to saturation were spotted onto 
medium containing sparsomycin (5 µg/ml), anisomycin (5 µg/ml), or paromomycin 
(600 µg/ml), as well as YPAD. Sensitivity was indicated by either a severe reduction 
or a complete lack of growth.
Computational Analyses
The crystal structure of the H. marismortui ribosome [25] was visualized 
using the Swiss PDB viewer.
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Chapter 3: Results
Frameshifting
The killer phenotypes of the rpl10 mutants and that of the wild type strain are 
shown in Figure 4A. qsr1-24 is clearly K-. Analysis of the dsRNA indicates that qsr1-
24 appears to be M1-  (Figure 4B), suggesting that the loss of the killer phenotype is 
the inability of qsr1-24 to support propagation of M1.
Changes in -1 PRF can cause loss of the killer phenotype in yeast. Therefore, 
as a quantitative measure of frameshifting, dual luciferase assays were performed to 
determine the exact percentage of PRF (Figure 5). The double mutant qsr1-24 
exhibited the most obvious deviation from wild type, with an efficiency of -1 PRF 
increased by more than two-fold of the wild type rate. A similar degree of variation in 
+1 PRF by this mutant was not found, which suggests the defect is more likely to be 
found in association with the ribosome's A-site. Both ts942 and grc5-1ts exhibit 
smaller increases in their -1 framshifting efficiencies, whereas qsr1-1 mimics wild 
type most closely. Little deviation was seen from wild type levels in +1 frameshifting, 
with all strains frameshifting near wild type efficiency.
Pharmacogenetics
In order to test the effects of the mutant forms of L10 on ribosomal affinity for 
aminoacyl- and peptidyl-tRNAs, a pharmacogenetic approach was carried out. 
(Figure 6) Anisomycin is known to bind in the A-site of the peptidyltransferase center 
[26], thereby inhibiting the binding of the acceptor end of the aminoacyl-tRNA into
14
A.          RPL10*     RPL10   ts942     grc5-1ts  qsr1-24  qsr1-1
  
 B.                             L-A 
            
M1
             
Figure 4: The mutants of RPL10 have differing effects on the yeast killer virus. 
(A) Killer assay of strains harboring either wild type or mutant alleles of RPL10. 
Killer activity is observed as a zone of growth inhibition around the colonies A wild-
type strain not inoculated with the killer virus (RPL10*)  is included for comparison. 
(B) Total RNA extracted from the strains described in (A) were separated through a 
1% TAE agarose gel. L-A and M1 form bands at 2.5 and 1.8 kbp respectively, as 
indicated.
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Figure 5: Efficiencies of -1 and +1 frameshifting in wild type and mutant strains. 
Efficiencies are depicted as percent frameshifting, which was calculated by dividing 
firefly/Renilla luminescence data from the appropriate reporter by similar ratios 
generated from cells expressing a zero-frame control plasmid.
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Figure 6: Strains harboring mutant forms of L10 have altered drug sensitivities.
Mid log phase cultures of the strains were spotted in ten-fold dilutions onto plain and 
drug-containing (anisomycin, 5µg/ml; sparsomycin, 5µg/ml; puromomycin, 
600µg/ml) media and grown for three days at 25oC.
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peptidyltransferase center [47,48], and thus is a good indicator of changes specific to 
the A-site. On anisomycin containing media, grc5-1ts exhibits a wild-type phenotype, 
whereas ts942 and qsr1-24 are slightly affected, and qsr1-1 displays the most altered 
phenotype. The exacerbated effect of anisomycin on these three mutants suggests a 
higher affinity of ribosomes containing these forms of L10 for aa-tRNAs, and point to 
these mutations, particularly that of qsr1-1, as A-site specific. When assayed for 
growth in the presence of sparsomycin, an indicator of P-site specific changes 
[reviewed in 49], little deviation from the wild-type profile was seen.  Paromomycin, 
another A-site specific probe known to stabilize the binding of near cognate tRNAs 
[50-52], caused hypersensitivity relative to wild type in grc5-1ts, which was least 
affected by anisomycin, reflecting the slight difference in binding between 
anisomycin and paromomycin [50,26]. ts942 and qsr1-24 also showed increased 
sensitivity to paromomycin, providing further confirmation of their A-site specificity.
18
Chapter 4: Discussion
Without proper maintenance of frame by the ribosome, cellular life could not 
exist. This, as well as the many other crucial functions of the ribosome, depend on the 
protein-protein and protein-RNA interactions within the structure. As such, ribosomal 
proteins have come to the forefront of recent research on the relationship between 
ribosomal structure and function.
It has previously been shown that L10 plays a crucial role in cellular and 
ribosomal function, impacting everything from cell wall formation to nonsense-
mediated decay and ribosomal export. Its precise role in the ribosome, however, is 
still under investigation. In this study, we have linked certain aspects of ribosomal 
function to specific sites within L10, particularly the mutation site in the strain qsr1-
24.
qsr1-24
Though located near grc5-1ts, the rare non-lethal double amino acid mutant at 
position 164-5 has a decidedly different phenotype from that of its neighbor. The 
mutation changes what was a polar, basic site to a bulky, nonpolar one at the site of 
the protein's closest approach to h42 – a site known for its flexibility during 
ribosomal translocation - and sandwiched between h42 and h38. The sharp increase in 
rates of -1 frameshifting abolished this strain's ability to support M1 and its secreted 
toxin. Due to the embedded location of this mutation, it is perhaps unsurprising that 
most of the tested antibiotics had little effect on the strain relative to wild type. Since 
paromomycin's interaction with the ribosome occurs at the decoding center, the 
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observed paromomycin sensitivity offers one possible explanation for the observed 
changes in frameshifting.  Perhaps this mutation points to a site involved in accuracy 
of the codon:anticodon contacts; the mutation alters this interaction sufficiently cause 
a more “slippery” A-site, leading to the observed alteration in in -1 PRF due to the 
intrinsically higher rate of error at the A-site. 
All mutants examined in the study showed effects related to the A-site of the 
ribosome, as expected, due to the location of L10 right where aa-tRNAs are loaded 
onto the large subunit. qsr1-24, in particular, merits further study to determine the 
precise role the KI164-5 site plays in A-site function. Furthermore, the strains used in 
this study were non-isogenic, and subsequent studies should be conducted to 
investigate whether the observed deviant phenotypes remain in isogenic strains.
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